Miseq sequencer and reagents
Ended Awarded Last action
- Contract number
- HHSF22301017T
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $996,000
Award facts
- Contract value 100% obligated
- $996,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $996,000 firm fixed-price delivery order to Illumina, Inc. for a MiSeq Sequencer and associated reagents on September 15, 2014, with an ultimate completion date of September 13, 2017. The award was issued to the San Diego-based biotechnology company without set-aside designation, reflecting Illumina's specialized position as the primary provider of next-generation DNA and RNA sequencing technologies to federal agencies. The delivery order procures essential laboratory equipment and consumables that support the FDA's scientific research and diagnostic capabilities across its regulatory and research functions.
This award represents a single delivery order transaction within Illumina's broader federal contracting portfolio, which includes substantial indefinite delivery contracts such as a $45 million IDIQ with the U.S. Department of Agriculture through June 2030. The MiSeq platform is a core component of Illumina's sequencing instrument offerings used across federal agencies for genomic analysis, infectious disease research, and diagnostic applications. The FDA's procurement of this sequencing system and associated reagents enables advanced genomic capabilities that support the agency's mission in food safety, pharmaceutical analysis, and regulatory science initiatives requiring comprehensive genetic sequencing and analysis capabilities.
Quick answers
Who was awarded contract HHSF22301017T?
HHSF22301017T was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 15, 2014.
How much is contract HHSF22301017T worth?
The government has obligated $996,000 on HHSF22301017T.
Is contract HHSF22301017T an order under another contract?
Yes. HHSF22301017T is a delivery order under HHSF223201210031I, an indefinite delivery contract.
Was contract HHSF22301017T competed?
The extent of competition for HHSF22301017T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award